159 related articles for article (PubMed ID: 31714912)
1. Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.
Walsh JS; Marshall H; Smith IL; Greenfield DM; Swain J; Best E; Ashton J; Brown JM; Huddart R; Coleman RE; Snowden JA; Ross RJ
PLoS Med; 2019 Nov; 16(11):e1002960. PubMed ID: 31714912
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
[TBL] [Abstract][Full Text] [Related]
4. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
[TBL] [Abstract][Full Text] [Related]
5. Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy.
Priskorn L; Kreiberg M; Bandak M; Lauritsen J; Daugaard G; Petersen JH; Aksglaede L; Juul A; Jørgensen N
Hum Reprod; 2021 Aug; 36(9):2443-2451. PubMed ID: 34223605
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
[TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
[TBL] [Abstract][Full Text] [Related]
10. Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial.
Christensen LL; Poulsen HE; Andersen MS; Glintborg D
Andrology; 2024 Jan; 12(1):115-122. PubMed ID: 37177884
[TBL] [Abstract][Full Text] [Related]
11. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
[TBL] [Abstract][Full Text] [Related]
15. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
[TBL] [Abstract][Full Text] [Related]
16. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
[TBL] [Abstract][Full Text] [Related]
17. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.
Hoyos CM; Yee BJ; Phillips CL; Machan EA; Grunstein RR; Liu PY
Eur J Endocrinol; 2012 Oct; 167(4):531-41. PubMed ID: 22848006
[TBL] [Abstract][Full Text] [Related]
18. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
[TBL] [Abstract][Full Text] [Related]
19. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
[TBL] [Abstract][Full Text] [Related]
20. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
